Increasing Age Affected Polymorphonuclear Neutrophils in Prognosis of Mycoplasma pneumoniae Pneumonia
Qianye Zhao1,2, Teng Zhang2, Beibei Zhu1
1Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Purpose:
It is well known that age is related to the incidence of Mycoplasma pneumoniae pneumonia (MPP), and how age and other factors contribute to MPP remains unclear. In this study, we investigate how age affects the prognosis of MPP.
Patients And Methods:
A total number of 1875 hospitalized children with pneumonia were enrolled in this study, including 52 children with refractory M. pneumoniae pneumonia (RMPP) and 298 children with non-RMPP. We used multiple logistic regression analysis to further identify the risk factors of RMPP, and found that age and polymorphonuclear neutrophils (PMNs) count were the key independent risk factors for the occurrence of RMPP. In order to improve specificity, 4.5 years old was taken as the cut-off value. Then, according to the cut-off value of age, 76 participants were recruited and divided into four groups: <4.5y MPP group, ≥4.5y MPP group, <4.5y health control (<4.5yHC) and ≥4.5y HC group. We explored the diverse functions of primary PMNs from children of different ages with MPP at cellular level. Besides, we studied the relationship between lung injury and PMNs in mice model with MPP of different ages.
Results:
We found that the age and PMNs count of RMPP group were significantly higher than those of the non-RMPP group. Importantly, there is a linear correlation between the age of patients with RMPP and the percentage of PMNs. Further analysis showed that elderly patients infected with M. pneumoniae had more active PMNs function. Meanwhile, proteomics showed that children with M. pneumoniae infection in different age groups have differences in PMNs apoptosis, nicotinamide adenine dinucleotide phosphate, mitochondrial function and oxidative stress. Finally, we found that age is also involved in the pathogenesis of mouse model with MPP.
Conclusion:
We speculate that age may contribute to the development of RMPP.
Insights
Age significantly impacts Mycoplasma pneumoniae pneumonia (MPP) outcomes. Older children with refractory MPP exhibit increased polymorphonuclear neutrophils (PMNs), suggesting age is a key factor in disease severity and development.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Respiratory Medicine
Background:
- Mycoplasma pneumoniae pneumonia (MPP) is a common childhood infection.
- The influence of patient age on MPP prognosis and severity is not fully understood.
- Refractory MPP (RMPP) represents a severe form of the disease with unclear contributing factors.
Purpose of the Study:
- To investigate the role of age in the prognosis and development of Mycoplasma pneumoniae pneumonia (MPP).
- To identify risk factors associated with refractory MPP (RMPP).
- To explore age-related differences in immune cell function and lung injury in MPP.
Main Methods:
- Retrospective analysis of 1875 hospitalized children with pneumonia, identifying RMPP and non-RMPP cases.
- Logistic regression analysis to determine risk factors for RMPP, with age and polymorphonuclear neutrophils (PMNs) identified as key.
- Cellular and molecular analysis of PMNs from children with MPP, stratified by an age cut-off of 4.5 years, and a murine model of MPP.
Main Results:
- Higher age and PMNs count were significantly associated with RMPP compared to non-RMPP.
- A linear correlation was observed between patient age and PMNs percentage in RMPP cases.
- Age-related differences in PMNs function, apoptosis, mitochondrial activity, and oxidative stress were noted in children with MPP; age also influenced MPP pathogenesis in a mouse model.
Conclusions:
- Age is a significant factor influencing the development and severity of refractory Mycoplasma pneumoniae pneumonia (RMPP).
- Increased PMNs activity and altered immune responses in older children may contribute to RMPP.
- Age-related mechanisms are implicated in MPP pathogenesis, warranting further investigation.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Drug Dosing: Geriatric Patients


